Meeting
2022 ASCO Annual Meeting
Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer.
Authors
Amy Body
Monash Health, Clayton, Australia
Amy Body , Claire Wakefield , Vi Thi Thao Luong , Mark Donoghoe , Noemi Auxiliadora Fuentes Bolanos , Antoinette Anazodo , Cindy Ho , Lisa Grech , Elizabeth Stephanie Ahern , Eva Segelov
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Health Promotion/Behaviors
Clinical Trial Registration Number
ACTRN12621001004853
Citation
J Clin Oncol 40, 2022 (suppl 17; abstr LBA12068)
DOI
10.1200/JCO.2022.40.17_suppl.LBA12068
Abstract #
LBA12068
Poster Bd #
314
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
The effect of corticosteroid on immunogenicity of SARS-CoV-2 vaccines in solid cancer patients.
First Author: Chayanee Samdaengpan
Poster
2023 ASCO Genitourinary Cancers Symposium
COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.
First Author: Danielle Gilbert
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny
Poster
2023 ASCO Quality Care Symposium
Improving bivalent COVID-19 vaccination rates among adult patients with cancer: An ASCO/CDC initiative.
First Author: Michael Jisoo Lee